MindMed is building an IP portfolio and undertaking clinical trials of medicines based on psychedelics. MindMed will also grow it’s pipeline through acquisitions, Joint-Ventures, and collaborative development agreements.
The company believes patients deserve better than to linger in symptom management forever. They help patients make breakthroughs that get them out of the symptom management cycle that’s all too commonplace in mental healthcare.